1696 related articles for article (PubMed ID: 18568314)
21. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
[TBL] [Abstract][Full Text] [Related]
22. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
[TBL] [Abstract][Full Text] [Related]
23. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
24. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
[TBL] [Abstract][Full Text] [Related]
25. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials.
Biondi-Zoccai GG; Agostoni P; Abbate A; Testa L; Burzotta F; Lotrionte M; Crea F; Biasucci LM; Vetrovec GW; Colombo A
Int J Cardiol; 2005 Apr; 100(1):119-23. PubMed ID: 15820294
[TBL] [Abstract][Full Text] [Related]
26. [Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions].
Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2183-6. PubMed ID: 16321180
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents.
Kereiakes DJ; Young JJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S48-58. PubMed ID: 15665798
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Patti G; Nusca A; Di Sciascio G
Am J Cardiol; 2008 Nov; 102(10):1328-34. PubMed ID: 18993150
[TBL] [Abstract][Full Text] [Related]
29. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
[TBL] [Abstract][Full Text] [Related]
30. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.
Garg P; Cohen DJ; Gaziano T; Mauri L
J Am Coll Cardiol; 2008 May; 51(19):1844-53. PubMed ID: 18466798
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
[TBL] [Abstract][Full Text] [Related]
32. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
Grube E; Dawkins KD; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Buellesfeld L; Koglin J; Russell ME
Eur Heart J; 2007 Nov; 28(21):2578-82. PubMed ID: 17938126
[TBL] [Abstract][Full Text] [Related]
33. Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
Gershlick A; Kandzari DE; Leon MB; Wijns W; Meredith IT; Fajadet J; Popma JJ; Fitzgerald PJ; Kuntz RE;
Am J Cardiol; 2007 Oct; 100(8B):45M-55M. PubMed ID: 17950832
[TBL] [Abstract][Full Text] [Related]
34. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
[TBL] [Abstract][Full Text] [Related]
35. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
Hermiller JB; Raizner A; Cannon L; Gurbel PA; Kutcher MA; Wong SC; Russell ME; Ellis SG; Mehran R; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1172-9. PubMed ID: 15837245
[TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.
Moses JW; Stone GW; Nikolsky E; Mintz GS; Dangas G; Grube E; Ellis SG; Lansky AJ; Weisz G; Fahy M; Na Y; Russell ME; Donohoe D; Leon MB; Mehran R
J Am Coll Cardiol; 2006 Jun; 47(11):2164-71. PubMed ID: 16750680
[TBL] [Abstract][Full Text] [Related]
37. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
Lansky AJ; Costa RA; Mooney M; Midei MG; Lui HK; Strickland W; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1180-5. PubMed ID: 15837246
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Stone GW; Suryapranata H; Laarman GJ; Menichelli M; Kaiser C; Valgimigli M; Di Lorenzo E; Dirksen MT; Spaulding C; Pittl U; Violini R; Percoco G; Marino P
Int J Cardiol; 2009 Apr; 133(2):213-22. PubMed ID: 18394731
[TBL] [Abstract][Full Text] [Related]
39. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
